Cardlytics, INC Form 4 insider transactions

NASDAQ
Cardlytics CFO Alexis DeSieno sold 26,048 shares of common stock at a weighted average price of $1.217 to cover tax obligations following the vesting of 43,750 restricted stock units.
NASDAQ
Cardlytics CEO Amit Gupta reported the vesting of 14,349 restricted stock units and the subsequent sale of 6,725 shares to cover tax withholding obligations.
NASDAQ
Cardlytics Chief Financial Officer Alexis DeSieno reported the acquisition of 14,349 common shares through restricted stock unit vesting and the subsequent sale of 7,324 shares at a weighted average price of $1.7826 to cover tax obligations.
NASDAQ
Cardlytics' Chief Legal & Privacy Officer, Nicholas Hollmeyer Lynton, reported the vesting of restricted stock units and a subsequent sale of shares solely to cover tax obligations.
NASDAQ
Clifford Sosin, a Director and 10% owner of Cardlytics, Inc., reported pro rata distributions of common stock and convertible senior notes to partners of investment vehicles he manages, with no consideration exchanged.
NASDAQ
Cardlytics, Inc. Chief Financial Officer Alexis DeSieno was granted 55,000 contingent equity awards, comprising Restricted Stock Units and Performance Stock Units, aligning her interests with shareholder value.
NASDAQ
Cardlytics, Inc. (CDLX) has granted its Chief Legal & Privacy Officer, Nicholas Hollmeyer Lynton, 25,000 Restricted Stock Units (RSUs) and 9,375 Performance Stock Units (PSUs) as part of his compensation.
NASDAQ
Cardlytics, Inc. has granted its Chief Executive Officer and Director, Amit Gupta, a total of 1.3 million contingent equity units, comprising Restricted Stock Units and Performance Stock Units, as part of his compensation.
NASDAQ
Director Scott A. Hill reports the vesting and conversion of restricted stock units into Cardlytics common stock.
NASDAQ
Director Liane Hornsey reports the vesting and conversion of restricted stock units into 11,000 shares of Cardlytics (CDLX) common stock on May 23, 2025.
NASDAQ
Director Jonathan Edward Francis reports the vesting and conversion of restricted stock units into common stock.
NASDAQ
Director John L. Klinck Jr. reports the vesting and conversion of restricted stock units into Cardlytics common stock.
NASDAQ
Director Andre J. Fernandez reports the vesting and disposal of 11,000 restricted stock units into Cardlytics common stock on May 23, 2025.
NASDAQ
Director Andre J. Fernandez acquired 11,000 restricted stock units in Cardlytics, Inc. on May 20, 2025, which will vest in full on the one-year anniversary of the grant date.
NASDAQ
Director John L. Klinck Jr. reports acquisition of 11,000 restricted stock units in Cardlytics, Inc.
NASDAQ
Director Jonathan Edward Francis acquired 11,000 restricted stock units in Cardlytics, Inc. on May 20, 2025, according to a Form 4 filing.
NASDAQ
Director Liane Hornsey acquired 11,000 restricted stock units (RSUs) of Cardlytics, Inc. on May 20, 2025, which will vest in full on the one-year anniversary of the grant date, provided she remains a director.
NASDAQ
Director Scott A. Hill acquired 11,000 restricted stock units in Cardlytics, Inc. on May 20, 2025, which will vest in full on the one-year anniversary of the grant date.
NASDAQ
Director Srishti A. Gupta acquired 11,000 restricted stock units in Cardlytics, Inc. on May 20, 2025, which will vest in full on the one-year anniversary of the grant date.
NASDAQ
Cardlytics' Chief Financial Officer, Alexis DeSieno, reports the acquisition and disposal of common stock and restricted stock units to cover tax obligations.
NASDAQ
Cardlytics' Chief Legal & Privacy Officer, Nicholas Hollmeyer Lynton, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.
NASDAQ
Director Liane Hornsey reports the vesting of restricted stock units into Cardlytics common stock.
NASDAQ
Cardlytics CEO Amit Gupta reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.
NASDAQ
Cardlytics' Chief Financial Officer, Alexis DeSieno, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.
NASDAQ
Cardlytics' Chief Legal & Privacy Officer, Nicholas Hollmeyer Lynton, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.
NASDAQ
Cardlytics' Chief Financial Officer, Alexis DeSieno, was granted performance-based and time-based restricted stock units on March 19, 2025.
NASDAQ
Chief Legal & Privacy Officer of Cardlytics, Inc., Nicholas Hollmeyer Lynton, reports the acquisition of performance stock units and restricted stock units.
NASDAQ
Cardlytics CEO Amit Gupta sold shares of common stock to cover tax obligations resulting from the vesting of restricted stock units (RSUs).
NASDAQ
Cardlytics' Chief Financial Officer, Alexis DeSieno, reported the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.
NASDAQ
Cardlytics' Chief Legal & Privacy Officer, Nicholas Lynton, reports the acquisition of 6,312 shares through performance stock units and the subsequent sale of 3,377 shares to cover tax obligations.